Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
CAMBRIDGE, Mass., Nov. 25, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a Fireside Discussion at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3rd at 10:30 AM EST.
美国马萨诸塞州剑桥市，2024年11月25日 /PRNewswire/ -- akebia therapeutics公司（纳斯达克：AKBA）是一家生物制药公司，旨在改善受到肾病影响的人的生活，今天宣布首席执行官约翰·巴特勒将参加于12月3日（星期二）上午10:30（东部标准时间）举行的第36届派杰投资医疗保健会议的炉边讨论。
A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at for 6 months following the conference.
演讲的网络直播可以通过akebia网站的“投资者”部分访问，可在会议后6个月内观看。
The Piper Sandler Healthcare Conference will take place December 3-5, 2024 in New York.
派杰投资医疗保健会议将于2024年12月3日至5日在纽约举行。
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at , which does not form a part of this release.
关于Akebia Therapeutics
Akebia Therapeutics，Inc.是一家完全整合的生物制药公司，旨在改善肾脏疾病患者的生活。Akebia成立于2007年，总部位于马萨诸塞州剑桥市。要了解更多信息，请访问我们的网站。
Akebia Therapeutics Contact
Mercedes Carrasco
[email protected]
Akebia Therapeutics联系方式
Mercedes Carrasco
[email protected]
SOURCE Akebia Therapeutics, Inc.
SOURCE Akebia Therapeutics，Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗？
译文内容由第三方软件翻译。
